HEALTH● LOW1h ago · Oct 21, 2026, 9:50 AM
Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
The Hindu · south asia
Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTHnowWHO supports Nigeria after first Ebola case confirmedUN NewsHEALTH14m agoNorah O'Donnell: What I learned from my melanoma diagnosisCBS NewsHEALTH17m agoNAFDAC to test non-US-made donated drugs, vaccines under Nigeria-US dealVanguard NigeriaHEALTH22m agoEbola: 5 things to know about Bundibugyo Strain as Nigeria confirms first caseVanguard Nigeria